We are live on ! Find out more
PHIO icon

Phio Pharmaceuticals
PHIO

3 hedge funds and large institutions have $2.5M invested in Phio Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding

Funds holding: 1 → 3 (+2)

16% less capital invested

Capital invested by funds: $2.98M → $2.5M (-$472K)

Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$2.13M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$709K

Top Sellers

Rank Fund Capital Flow
1
SIM
Spark Investment Management
New York
-$57K
2
Citadel Advisors
Citadel Advisors
Florida
-$19K
3
ARTA
A.R.T. Advisors
New York
-$18K
4
Deutsche Bank
Deutsche Bank
Germany
-$8K
5
TRCT
Tower Research Capital (TRC)
New York
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tang Capital Management
California
$1.13M +$2.13M +3 New
BC
2
Broadfin Capital
New York
$811K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$226K +$709K +1 New
TAM
4
Tocqueville Asset Management
New York
$90K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$60K – – –
CS
6
Credit Suisse
Switzerland
$55K – – –
Nomura Holdings
7
Nomura Holdings
Japan
$30K – – –
BW
8
Bison Wealth
Georgia
$25K – – –
Goldman Sachs
9
Goldman Sachs
New York
$19K – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$15K – – –
VKH
11
Virtu KCG Holdings
New York
$15K – – –
Northern Trust
12
Northern Trust
Illinois
$11K – – –
Bank of America
13
Bank of America
North Carolina
$10K – – –
BIM
14
BlackRock Investment Management
Delaware
$2K – – –
AIG
15
American International Group
New York
$1.44K – – –
LTFS
16
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Morgan Stanley
17
Morgan Stanley
New York
$1K – – –
ARTA
18
A.R.T. Advisors
New York
– -$18K – –
Citadel Advisors
19
Citadel Advisors
Florida
– -$19K – –
Deutsche Bank
20
Deutsche Bank
Germany
– -$8K – –
SIM
21
Spark Investment Management
New York
– -$57K – –
TRCT
22
Tower Research Capital (TRC)
New York
– -$5K – –

PHIO Hedge Fund Activity: Q1 2015 in Review

3 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q1 2015, worth a combined $2.5M — down 16% from $2.98M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PHIO positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $2.13M. The largest seller was Spark Investment Management, cutting an estimated $57K.

  • 3 institutional investors held Phio Pharmaceuticals (PHIO) as of Q1 2015, up from 1 in Q4 2014.
  • Funds reported $2.5M of Phio Pharmaceuticals stock for Q1 2015, down 16% quarter-over-quarter.
  • 2 funds opened new Phio Pharmaceuticals positions in Q1 2015 and 0 closed out, a net change of +2 holders.
  • The largest Phio Pharmaceuticals buyer in Q1 2015 was Tang Capital Management, an estimated $2.13M added.
  • The largest Phio Pharmaceuticals seller in Q1 2015 was Spark Investment Management, an estimated $57K sold.

Based on aggregated 13F filings for Q1 2015.